Apple Inc. (NASDAQ:AAPL): After Topeka conducted checks, it believes that Apple will launch a TV that will “revolutionize the TV experience” during 2H13. Also, the 60 inch TV is to include a miniature device incorporating motion detector technology and acting as a “navigation pointer,” the firm claims. Furthermore, a mini screen will be incorporated, providing other types of functionality including video conferencing, added the firm, which which has decided to keep its Buy rating and a $888 price target on the stock. According to Bernstein, the lower price of the iPad mini and Apple’s stronger ecosystem is to assist in preventing Google’s (NASDAQ:GOOG) Android from taking over the tablet market. The firm has stated that iPad mini cannibalization can only reduce the company’s EPS by as much as 3 percent, and it keeps its Outperform rating and a $725 price target on the shares.
Align Technology Inc. (NASDAQ:ALGN): After the firm spoke with 156 providers of Align’s Invisalign clear braces, Stifel thinks thatthat Invisalign trends improved last quarter, and the firm believes that Align could be in the position to report stronger than expected results for the quarter. It keeps its Buy rating and a $38 price target on the stock.
Delta Air Lines Inc. (NYSE:DAL): According to Cowen, the pullback in Delta Air Lines should be purchased, as the firm believes that the fundamentals continue to be strong and the company will likely post Q1 profits for the first time in over a decade. The firm gives the shares a Buy rating and a $19 price target.
Dendreon Corp. (NASDAQ:DNDN): The company’s recently initiated TV ads for Provenge is viewed by Leering as increasing patient interest. The firm has stated that according to Google Trends, web searches for the company’s prostate cancer drug saw a rise to their highest levels in two years. However, Leerink has stated that the sales impact from the ads continue to be unclear, and it reiterates its Market Perform rating on the stock.